Please assess the completion status of the following clinical trial:

Trial Title: The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* unilateral limbus defect larger than 180 degrees~* repeated corneal epithelial ulcer, loss of visual acuity or neovascularization due to limbal stem cell insufficiency~* no improvement after medical intervention for more than 6 months~* the patient is willing to receive surgery and postoperative follow up~Exclusion Criteria:~* bilateral limbus defect~* limbal stem cell insufficiency does not induce repeated corneal epithelial ulcer, loss of visual acuity or neovascularization~* corneal neovascularization deeper than 1/2 depth of surface matrix~* peripheral surface matrix is less than 200um thick~* no corneal reflex was induced by fiber less than 5mm length measured by Cocet-Bonnet esthesiometer~* improvement under medication~* perisurgical follow up less than 6 months~* unable to be long term followed up postoperatively~* glaucoma patients underwent glaucoma surgery, under medication, IOP \> 21mmHg~* glaucoma patients underwent glaucoma surgery, under medication, IOP \< 21mmHg, optic disc depression \> 90%~* severe incomplete eyelid closure~* severe dye eye syndrome, Schirmer test 5 min \< 3 mm~* contralateral eye limbus tissue cannot be obtained, or unable to be cultured~* pregnant

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Patients suffering from unilateral limbal stem cell insufficiency. Remove the abnormal surface tissue on the lesion cornea, transplant the amniotic membrane with cultured limbal stem cells on the denuded cornea. Cover with contact lens after operation, and apply topical antibiotics and steroids.

Based on this trial design, predict the completion outcome and termination type (if applicable).